SCHEMBL9801566

SCHEMBL9801566

CNc1cccc(NC)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 2/20 0.46
POLB P06746 2/20 0.46
RECQL P46063 2/20 0.46
USP2 O75604 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
EGFR P00533 1/20 0.41
PABPC1 P11940 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
PDK1 Q15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22779822 0.86 MAPT (0.47) MAPTALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL1548708 0.86 KEAP1 (0.54) MAPTALDH1A1TDP1HSD17B10MAPK1
Hydrochloric Acid SCHEMBL2871283 0.84 KEAP1 (0.52) MAPTALDH1A1TDP1HSD17B10MAPK1
SCHEMBL9232217 0.82 MAPT (0.53) MAPTALDH1A1KDM4EPOLBUSP2
SCHEMBL30368237 0.82 MAPT (0.53) MAPTALDH1A1KDM4EPOLBUSP2
SCHEMBL8310698 0.82 TRPA1 (0.52) MAPTALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL14857685 0.82 ALDH1A1 (0.39) MAPTALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL19277812 0.82 MAPT (0.38) MAPTALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL9230273 0.82 ALDH1A1 (0.49) MAPTALDH1A1TDP1L3MBTL1KDM4E
SCHEMBL14861504 0.82 ALDH1A1 (0.39) MAPTALDH1A1TDP1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5071947-A Polymerization of a bismaleimide and an aromatic secondary diamine in the presence of dicumyl peroxide and imidazole mixed catalyst LUCKY, LTD. (KR) 1991-12-10 US claimed
WO-2020011246-A1 BENZENE RING-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 广州丹康医药生物有限公司 2020-01-16 WO disclosed
US-7777063-B2 Organosilicon compounds their preparation and their use EVONIK DEGUSSA GMBH (DE) 2010-08-17 US disclosed
US-7777063-B2 Organosilicon compounds their preparation and their use EVONIK DEGUSSA GMBH (DE) 2010-08-17 US disclosed
US-20080275152-A1 Halogen-free, flame-retardant polyurethane foams LANXESS DEUTSCHLAND GMBH 2008-11-06 US disclosed
US-20080275152-A1 Halogen-free, flame-retardant polyurethane foams LANXESS DEUTSCHLAND GMBH 2008-11-06 US disclosed
EP-1964880-A1 Halogen-free flame-resistant polyurethane foams Lanxess Deutschland GmbH (DE) 2008-09-03 EP disclosed
US-20070066760-A1 Organosilicon compounds their preparation and their use DEGUSSA AG (DE) 2007-03-22 US disclosed
US-20070066760-A1 Organosilicon compounds their preparation and their use DEGUSSA AG (DE) 2007-03-22 US disclosed
US-5071947-A Polymerization of a bismaleimide and an aromatic secondary diamine in the presence of dicumyl peroxide and imidazole mixed catalyst LUCKY, LTD. (KR) 1991-12-10 US disclosed
US-5004774-A Heat resistance, shrinkage inhibition LUCKY, LTD. (KR) 1991-04-02 US disclosed
US-3943158-A POLYURETHANE MONOMERS BAYER AKTIENGESELLSCHAFT (DT) 1976-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066760-A1 Organosilicon compounds their preparation and their use MSH6, MCM6, SI MAPT 1545/4885ALDH1A1 1519/4885TDP1 1740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.